按首字母搜索

产品名字索引 N

• NPD-3519 (Catalog# : 24089, Cas# : 3032452-90-4)
• NDI-091143 (Catalog# : 24057, Cas# : 2375840-87-0)NDI-091143 is a novel potent inhibitor of human ATP-citrate lyase, indirectly disrupt
• NMD670 (Catalog# : 24050, Cas# : 2354321-33-6)NMD670 is an orally bioavailable skeletal muscle-specific chloride ion channel (ClC-1
• NNC-55-0396 (Catalog# : 24038, Cas# : 357400-13-6)NNC-55-0396是一种高选择性T型钙通道阻滞剂，可用于神经系统疾病研
• NVL-655 ( ALK-IN-27 ) (Catalog# : 24003, Cas# : 2739866-40-9)NVL-655是一种新型脑渗透性ALK选择性抑制剂，旨在解决目前可用的
• Navacaprant (Catalog# : 23122601, Cas# : 2244614-14-8)Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿
• Ninerafaxstat (Catalog# : 20608, Cas# : 2254741-41-6)Ninerafaxstat is a biochemical that decreases fatty acid oxidation and improves mitoc
• NBI-921352 (Catalog# : 20602, Cas# : 2154406-04-7)NBI-921352 is a potent, highly selective Nav1.6 sodium channel inhibitor being develo
• Navitoclax-piperazine (Catalog# : 20559, Cas# : 2143096-93-7)Navitoclax-piperazine, also known as ABT-263-piperazine, is a Navitoclax derative and
• NMS-293 ( NMS-P293 ) (Catalog# : 20514, Cas# : 1606996-12-6)NMS-293 是 Nerviano Medical Sciences 处于早期临床开发阶段的 PARP-1 抑制
• NSC348884 (Catalog# : 20487, Cas# : 81624-55-7)NSC348884 is a nucleophosmin inhibitor. NSC348884 also disrupts oligomer formation an
• NSC-92828 (Catalog# : 20486, Cas# : 13728-56-8)NSC-92828, also known as 3-Phenanthrenebutyric acid, is a Protein–protein interacti
• NSC-45586 (Catalog# : 20483, Cas# : 6300-44-3)NSC-45586 is a pan-PHLPP inhibitor selective for PHLPP1 and PHLPP2.
• NXP-800 ( CCT361814 ) (Catalog# : 233141, Cas# : 1693734-80-3)NXP800 是一种口服小分子热休克因子 1 (HSF1) 通路抑制剂。 NXP800 可
• Nefazodone (Catalog# : 20463, Cas# : 83366-66-9)Nefazodone is an antidepressant. Its chemical structure is unrelated to selective ser
• NBD-14270 (Catalog# : 20448, Cas# : 2411819-82-2)
• NXY-059 ( Disufenton Sodium ) (Catalog# : 52014, Cas# : 168021-79-2)Disufenton sodium (NXY-059) 是神经保护剂phenylbutynitrone的衍生物，具有极
• N-Benzyl-2,6-difluoro-3,5-dimethoxyaniline (Catalog# : 20411, Cas# : 651734-53-1)
• N-(6-bromo-2-ethyl-8-methylimidazo[1,2-a]pyridin-3-yl)formamide (Catalog# : 20402, Cas# : 1628263-77-3)
• N-(6-bromo-2-ethyl-8-methylimidazo[1,2-a]pyridin-3-yl)-N-methylformamide (Catalog# : 20401, Cas# : 1628263-96-6)
• N,N-DIETHYL-2,6-CIS-DIMETHYLPIPERIDINIUM IODIDE (Catalog# : G20383, Cas# : 1335241-44-5)
• Navoximod free base (Catalog# : 20290, Cas# : 1402837-78-8 (free base))
• NE 52-QQ57 (Catalog# : 21233, Cas# : 1401728-56-0)NE52-QQ57 is an orally available GPR4 antagonist with an IC50 of 70 nM. NE 52-QQ57 si
• NVS-PAK1-1 (Catalog# : 21231, Cas# : 1783816-74-9)NVS-PAK1-1 is a a specific allosteric PAK1 inhibitor.
• Niraparib tosylate hydrate (Catalog# : 2021115, Cas# : 1613220-15-7)Niraparib, also know as MK-4827, is an inhibitor of poly (ADP-ribose) polymerase (PAR
• N-(8-Benzyl-8-azabicyclo[3.2.1]oct-3-yl-exo)-2-methylpropanamide (Catalog# : 2071632, Cas# : 376348-67-3)
• NCC007 (Catalog# : 2071529)NCC007 is a novel CKIα and CKIδ dual inhibitor. NCC007 that showed stronger period
• N-tert-butyl-3-[(2-chloro-5-methylpyrimidin-4-yl)amino]benzenesulfonamide (Catalog# : 2062304, Cas# : 936092-53-4)
• N,N-dibenzyl-6-chloro-5-nitropyrimidine-4-amine (Catalog# : 2062033, Cas# : 882272-97-1)
• N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine (Catalog# : 2062032, Cas# : 1346133-39-8)